
Drug Target Models
GPCR Reporter Cells
Immunotherapy cells
Other Stable Cells
Assay Kits & Reagents
Services
Resources
Company
Cat. No: RQP74225
Size: 1 vial of frozen cells (>1E6 per vial in 1 mL)
Unit Price: Contact For Pricing
| Cat. No | RQP74225 |
| Product Name | HEK293 Human Activin A Effector Reporter Cell |
| Product Type | Reporter Cell |
| Culture Properties | Adherent |
| Stability | 32passages (in-house test, that not means the cell line will be instable beyond the passages we tested.) |
| Mycoplasma Status | Negative |
| Culture Medium | DMEM+10%FBS+200 μg/ml Hygromycin B |
| Freeze Medium | 90% FBS+10% DMSO |
| Storage Conditions | Liquid nitrogen immediately upon delivery |
| Application | Functional(Report Gene) Assay |
For research use only. Not intended for human or animal clinical trials, therapeutic or diagnostic use.
Activin A is an important member of the transforming growth factor-β (TGF-β) superfamily, a pleiotropic factor involved in the pathogenesis of immune dysregulatory diseases such as allergies, autoimmune disorders, and cancer.
Activin A signals through two types of I receptors and two types of II receptors, which assemble into the final receptor complex upon ligand binding. The I receptors include type I activin receptor (or activin receptor-like kinase 2, ALK2), type IB activin receptor (or ALK4), and type IC activin receptor (or ALK7). Activin A has a preference for ALK4 binding and exhibits lower affinity for ALK2 and ALK7. The II receptors are Activin Receptor Type IIA (ActRIIA) and Activin Receptor Type IIB (ActRIIB), characterized by constitutively active serine/threonine kinase activity. Once Activin A binds to its II-type receptor, two I-type receptors are recruited and phosphorylated by the II-type receptor, an event that activates their kinase activity. Most TGF-β superfamily members bind to ActRIIB or ActRIIA, while only a few ligands bind with high affinity to ALK4. In addition to the canonical receptor serine/threonine kinase-Smad pathway, Activin A has been shown to participate in pathways such as P38, ERK, PI3K, and WNT.
The Activin A Effector Reporter Cell reporter gene drug target model effectively simulates the signal transduction process of Activin A in vivo, with the principle shown in the figure below.

Figure 1. Schematic of the Activin A Effector Reporter Cell Model.
| Classification | Cytokine&Growth Factor |
| Family | Transforming growth factor-β (TGF-β) receptor family |
| Gene Name | ACVR2A |
| Gene Aliases | ACVR2;ACTRII;activin A receptor, type II;activin A receptor, type IIA |
| Gene ID | 92 |
| Accession Number | NM_001616.5 |
| UniProt Number | P27037 |
| Protein Name | Activin receptor type-2A |
| Protein Aliases | Activin receptor type IIA (ACTR-IIA; ACTRIIA) |
| Family-2 | TGF-beta family |
| Gene Name-2 | MSTN |
| Gene Aliases-2 | GDF8 |
| Gene ID-2 | 2660 |
| Accession Number-2 | NM_005259.3 |
| UniProt Number-2 | O14793 |
| Protein Name-2 | GDF-8 |
| Protein Aliases-2 | Myostatin |
| Family-3 | TGF-beta family |
| Gene Name-3 | GDF11 |
| Gene Aliases-3 | BMP-11;BMP11 |
| Gene ID-3 | 10220 |
| Accession Number-3 | NM_005811.5 |
| UniProt Number-3 | O95390 |
| Protein Name-3 | GDF-11 |
| Protein Aliases-3 | BMP-11 |
| Target Species | Human |
| Host cell | HEK293 |
Figure 2. Dose Response of Recombinant Human Activin A in Activin A Effector Reporter Cell( C27).Dose Response of Recombinant Human GDF-8 in Activin A Effector Reporter Cell( C27).Dose Response of Recombinant Human GDF-11 in Activin A Effector Reporter Cell(C27).

Figure 3. Inhibition of Human GDF-8 induced Reporter Activity by ActR II Blocking Ab in Activin A Effector Reporter Cell(C27). Inhibition of Human GDF-11 induced Reporter Activity by ActR II Blocking Ab in Activin A Effector Reporter Cell(C27).

Figure 4. Inhibition of Human Activin A induced Reporter Activity by Activin A Ab in Activin A Effector Reporter Cell(C27). Inhibition of Human Activin A induced Reporter Activity by ActR II Blocking Ab in Activin A Effector Reporter Cell(C27).
Cell Resuscitation
1)Rapidly thaw the frozen cells in a 37 °C water bath for approximately 60 seconds. Once thawed (which may take slightly less or more than 60 seconds), immediately transfer the cell suspension from the cryovial into a 15 mL centrifuge tube containing 10 mL of pre-warmed HEK293 Human Activin A Effector Reporter Cell complete culture medium.
2)Centrifuge cells at 1000 rpm for 5 min to remove medium, then resuspend cells in 5 mL of pre-warmed complete medium.
3)Transfer the cell suspension into a T25 culture flask and incubate at 37 °C with 5% CO₂.
4)After approximately 24–36 hours, replace the medium or passage the cells to remove non-adherent dead cells.
Subculturing procedure
1)When the cell density reaches the appropriate confluency for passaging, wash the cells with PBS, then add 1 mL trypsin to detach the cells. When more than 80% of the cells detach upon gently tapping the culture flask, add complete culture medium to terminate digestion. Gently pipette to obtain a single-cell suspension, transfer to a 15 mL centrifuge tube, and centrifuge at 1000 rpm for 5 minutes.
2)Discard supernatant after centrifugation. Resuspend cells in fresh medium to a single-cell suspension and transfer to a new culture flask for continued growth.
Cell Freezing
After trypsinization and centrifugation of cells from each T75 flask or 10 cm culture dish, discard the supernatant. Add 2 mL of cryopreservation medium (90% FBS + 10% DMSO), gently resuspend thoroughly, and aliquot into two cryovials. Immediately place the cryovials into a controlled-rate freezing container (e.g., Nalgene 5100-0001), fill with isopropanol to the indicated level, and store at −80 °C. After 24 hours, transfer the cryovials to liquid nitrogen for long-term storage.
We Are Pleased to Announce: Global Commercial Licensing Rights for Jurkat E6.1, CHO-K1, and HEK293 Cell Lines Officially Secured.
Explore